The Centers for Medicare & Medicaid Services (CMS) recently released premium and cost-sharing information for Part D plans for the 2020 calendar year. Below are the highlights of a preliminary analysis.
The government currently has no plan for what to do when the money runs short. What are the current possibilities in play? Here is Dr. Steven Weisbart, Chief Economist at the Insurance Information Institute.
This funding is part of $250 million for State Rate Review Grants provided by the PPACA to improve the process for how States review proposed health insurance rates.
“With faster processing times and earlier communication, states now have much greater ability to manage their programs in an effective and predictable manner,” said CMS Administrator Seema Verma. “We want to ease bureaucratic requirements for both states and our own staff so that we can focus those resources on improving health outcomes rather than pushing paperwork.”
Today, the Centers for Medicare & Medicaid Services (CMS) introduced much-needed competition and negotiation into the market for physician-administered and other Part B medications that will result in better deals and lower drug costs for patients.
Today, the Centers for Medicare & Medicaid Services (CMS) announced that, for the second year in a row, the average basic premium for a Medicare Part D prescription drug plan in 2019 is projected to decline.
© 2025 Trusted American Insurance Agency, All Rights Reserved | Lic. 0J15378
